SUN-523 XLH Outcome Data from One Centre Experience with Burosumab

X-linked hypophosphataemia (XLH) is a rare, genetic, chronically debilitating and deformative bone disease that profoundly impacts the affected individual’s day-to-day functioning and quality of life. High levels of circulating fibroblast growth factor 23 (FGF23) lead to excess urinary phosphate exc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Endocr Soc
Main Authors: Cheung, Moira, Sakka, Sophia, Gilbey-Cross, Robyn, Harries, Mark, Mathieson, Leigh
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2019
Fag:
Bone and Mineral Metabolism
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553073/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-523
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker